SCHEMBL79819

SCHEMBL79819

CCC(CCc1ccc(OCCCc2ccc(C(F)(F)F)cc2)c(C(F)(F)F)c1)(COCOC)NC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.40
PPARA Q07869 5/20 0.36
PPARD Q03181 4/20 0.36
AAK1 Q2M2I8 8/20 0.35
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
PPARG P37231 3/20 0.35
PTGES O14684 1/20 0.34
ALOX5 P09917 1/20 0.34
S1PR4 O95977 1/20 0.34
S1PR3 Q99500 1/20 0.34
S1PR5 Q9H228 1/20 0.34
RXRA P19793 2/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
NR1H2 P55055 1/20 0.34
PSEN1 P49768 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80319 0.91 S1PR1 (0.39) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL79557 0.91 S1PR1 (0.39) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL13851953 0.90 S1PR1 (0.52) S1PR1AAK1S1PR4S1PR3S1PR5
SCHEMBL79734 0.90 S1PR1 (0.39) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL79459 0.89 S1PR1 (0.40) S1PR1PPARAPPARDAAK1KDM4E
SCHEMBL79775 0.88 S1PR1 (0.37) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL80206 0.88 S1PR1 (0.37) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL80614 0.87 S1PR1 (0.40) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL80632 0.87 S1PR1 (0.40) S1PR1PPARAPPARDAAK1PPARG
SCHEMBL79403 0.87 S1PR1 (0.40) S1PR1PPARAPPARDAAK1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168944-B1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-11 EP disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
EP-2168944-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2010-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C S1PR1 511/4885PPARA 601/4885PPARD 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.